Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential thrombocythaemia.

K K Mathew1, Gloria Fernande, Chitra Shenoy

  • 1Department of Hematology, Coney Island Hospital, Brooklyn, New York, USA.

Journal of the Indian Medical Association
|October 31, 2002
PubMed
Summary

Essential thrombocythemia, a blood disorder, was effectively treated in a patient using aspirin and hydroxyurea. This case highlights the successful management of essential thrombocythemia with these common therapeutic agents.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imipramine in persistent vomiting.

Journal of the Indian Medical Association·2007
Same author

Metronidazole in primary cholangitis.

Journal of the Indian Medical Association·1983
Same author

Tracer studies of the distribution and trypanocidal action of stilbamidine in rats.

British journal of pharmacology and chemotherapy·1959
Same author

Synthesis of yohimbine and related ring structures.

Current science·1949

Area of Science:

  • Hematology
  • Oncology

Background:

  • Essential thrombocythemia is a myeloproliferative neoplasm characterized by elevated platelet counts.
  • Management aims to prevent thrombotic and hemorrhagic complications.

Observation:

  • A single case of essential thrombocythemia is presented.
  • The patient exhibited a positive response to treatment.

Findings:

  • The patient's essential thrombocythemia responded well to a combination therapy of aspirin and hydroxyurea.
  • This indicates the efficacy of these agents in managing the condition.

Implications:

  • This case supports the use of aspirin and hydroxyurea as a viable treatment strategy for essential thrombocythemia.
  • Further research may explore optimal dosing and long-term outcomes.